Navigation Links
New Ribosome Finding Could Lead to Antiviral Therapies

The ribosome is the protein-producing nanomachine in cells that keeps the human body cranking along. A discovery by University of Maryland researchers// has provided a clue that could lead to programming the ribosome to fight viruses like HIV AIDS and SARS.

In the March 23 issue of the journal Molecular Cell, University of Maryland biology professor Jonathan Dinman and research assistant professor Artural Meskauskas describe how their discovery of the function of some long protein finger-like structures in the ribosome could lead to new antiviral therapies in the near future.

“One such finger, located in a ribosomal protein called L3, acts as a switch to help the ribosome coordinate all of its functions,” said Dinman. “We found that by altering this switch, the cell lost its ability to propagate viruses. If we could mimic this, we could target the L3 protein for antiviral therapies.”

Turning Off A Virus
The ribosome is a complex molecular machine that makes proteins, the molecular building blocks of our bodies. “I think of the ribosome as a nanomachine that coordinates events in a sequential order,” Dinman said. “The core of the ribosome is made up mostly of RNA, and this does most of the heavy lifting. But the outsides of ribosomes are also decorated with proteins, and these tend to have long tentacle-like structures that extend deep into ribosomal cores.”

According to Dinman and Meskauskas’ paper, previous studies have shown that L3 plays an important role in a number of cellular functions, including drug resistance and virus replication.

“The finger-like extensions of L3 may help coordinate ribosome-associated functions by acting as a switch or a gatekeeper,” Dinman said. “When you alter the L3 switch, you alter the way the ribosome coordinates all of the functions of the cell. We found that the cells with this L3 mutation could not reproduce viruses.

“These mutant forms of L3 also made cells resistant to certain antibiotics. Understanding how these mutants affect the interactions between ribosomes and factors that lead to drug resistance can provide the foundation for design of new antibacterials to counter resistance of pathogens to drugs,” said Dinman. “This study also provides a basis for deeper insight into design of small molecule antiviral therapies, hopefully in the near future.”

Source-ewswise
SRM
'"/>




Related medicine news :

1. Finding relief from Excruciating Headaches a challenge
2. Latest Findings On The Deadly Disease - SARS
3. New Findings Could Reduce The Extent Of Spinal Cord Injuries
4. Surprising Cystic Fibrosis Finding That Could Be A Helpful Treatment Option
5. New Findings for Repeated Miscarriages
6. Finding The Key To Weight Loss!
7. Internet Helps Patients In Finding Info About Their Childrens Health Conditions
8. How Healthy Are Herbal Products? US Findings.
9. Dispute in Findings about Radiation exposure
10. New Findings on Autism Research
11. Engineering Nutrient-Rich Plants Made For Feasible By New Findings
Post Your Comments:
*Name:
*Comment:
*Email:


(Date:10/12/2017)... ... October 12, 2017 , ... CitiDent ... sleep apnea using cutting-edge Oventus O2Vent technology. As many as 18 million ... by frequent cessation in breathing. Oral appliances can offer significant relief to about ...
(Date:10/12/2017)... ... October 12, 2017 , ... The ... demand of today’s consumer and regulatory authorities worldwide. From Children’s to Adults 50+, ... to meet the highest standard. , These products are also: Gluten Free, ...
(Date:10/12/2017)... ... October 12, 2017 , ... The American College of Medical Informatics (ACMI) ... FACMI, during the Opening Session of AMIA’s Annual Symposium in Washington, D.C. AMIA’s ... Morris F. Collen, a pioneer in the field of medical informatics, this prestigious award ...
(Date:10/12/2017)... ... 2017 , ... Information about the technology: , Otomagnetics has ... prevention of a major side effect of chemotherapy in children. Cisplatin and carboplatin ... cisplatin, hearing loss is FDA listed on-label as a dose limiting toxicity. Hearing ...
(Date:10/12/2017)... ... October 12, 2017 , ... HMP , a ... of a 2017 Folio Magazine Eddie Digital Award for ‘Best B-to-B Healthcare Website.’ Winners ... October 11, 2017. , The annual award competition recognizes editorial and design excellence across ...
Breaking Medicine News(10 mins):
(Date:10/2/2017)... Oct. 2, 2017  Eli Lilly and Company (NYSE: ... for the third quarter of 2017 on Tuesday, October ... on that day with the investment community and media ... The conference call will begin at 9 a.m. Eastern ... a live webcast of the conference call through a ...
(Date:10/2/2017)... Halo Labs announces the European launch of their new ... at MIBio 2017 in Cambridge, U.K on ... in biopharmaceutical samples with unprecedented speed and sensitivity while using far ... Membrane Imaging. ... particle analysis system ...
(Date:9/28/2017)... Sept. 28, 2017 Hill-Rom Holdings, Inc. (NYSE: ... conference call and webcast on Friday, November 3, 2017, ... and ending at approximately 8:30 a.m. (CDT) / 9:30 ... company,s 2017 financial performance and guidance for 2018, Hill-Rom ... to enhance operational performance, and long-range financial outlook through ...
Breaking Medicine Technology: